U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 19:58:38 GMT 2025
Edited
by admin
on Wed Apr 02 19:58:38 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
A2X6JB3B7U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
H-gamma1 heavy chain humanized (1-448) [VH (Homo sapiens IGHV1-69-2*01 (86.5%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.11] (26-33.51-58.97-107)) (1-118) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, G1v78 CH3 L107, A114 (CH1 K120 (215) (119-216
Preferred Name English
Turenkibart
INN  
Official Name English
Immunoglobulin G1 [429-leucine,435-alanine], anti-(human interleukin 17A) (human-Mus musculus monoclonal SCT650C ?1-chain), disulfide with human-Mus musculus monoclonal SCT650C ?-chain, dimer
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens IL17A (Interleukin 17A, IL-17), humanized monoclonal antibody
Common Name English
turenkibart [INN]
Common Name English
Code System Code Type Description
CAS
2761187-73-7
Created by admin on Wed Apr 02 19:58:38 GMT 2025 , Edited by admin on Wed Apr 02 19:58:38 GMT 2025
PRIMARY
NCI_THESAURUS
C211753
Created by admin on Wed Apr 02 19:58:38 GMT 2025 , Edited by admin on Wed Apr 02 19:58:38 GMT 2025
PRIMARY
FDA UNII
A2X6JB3B7U
Created by admin on Wed Apr 02 19:58:38 GMT 2025 , Edited by admin on Wed Apr 02 19:58:38 GMT 2025
PRIMARY
SMS_ID
300000056828
Created by admin on Wed Apr 02 19:58:38 GMT 2025 , Edited by admin on Wed Apr 02 19:58:38 GMT 2025
PRIMARY
INN
12621
Created by admin on Wed Apr 02 19:58:38 GMT 2025 , Edited by admin on Wed Apr 02 19:58:38 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_145 2_201
2_221 4_220
2_262 2_322
1_145 1_201
2_368 2_426
3_23 3_94
3_140 3_200
4_23 4_94
4_140 4_200
1_221 3_220
1_227 2_227
1_230 2_230
1_262 1_322
1_368 1_426
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
N 3_31
N 4_31
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_448] [2_448] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL